Author： Antoniu Sabina A
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.3, 2007-03, pp. : 393-395
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Erlotinib: Fatal interstitial lung disease: case report
Reactions Weekly, Vol. 1, Iss. 1176, 2007-01 ,pp. :
Access to resources
Recommend
Gefitinib: Interstitial lung disease: case report
Reactions Weekly, Vol. 1, Iss. 1180, 2007-01 ,pp. :
Antineoplastics: Interstitial lung disease: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1351, 2011-01 ,pp. :
Gefitinib: Interstitial lung disease: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1391, 2012-01 ,pp. :
Nitrofurantoin: Interstitial lung disease: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1430, 2012-01 ,pp. :